GV 2017, L.P. Updates Passive Stake in TScan Therapeutics

Ticker: TCRX · Form: SC 13G/A · Filed: 2024-02-09T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, amendment, passive-investment

TL;DR

**GV 2017, L.P. (Alphabet-backed) just updated its passive TScan Therapeutics stake.**

AI Summary

GV 2017, L.P., a venture capital firm associated with Alphabet Inc., filed an amended Schedule 13G/A on February 9, 2024, indicating a change in their beneficial ownership of TScan Therapeutics, Inc. Voting Common Stock as of December 31, 2023. This filing, made under Rule 13d-1(d), suggests a passive investment update rather than an aggressive stake. For investors, this means a significant institutional holder is adjusting its position, which could signal a re-evaluation of TScan's future prospects by a sophisticated investor.

Why It Matters

This filing shows a major institutional investor, GV 2017, L.P. (linked to Alphabet), has updated its position in TScan Therapeutics, which can influence market perception and investor confidence in the stock.

Risk Assessment

Risk Level: low — This is an amendment to a passive filing, indicating a routine update rather than an aggressive or hostile action.

Analyst Insight

An investor should note that a major institutional investor (GV 2017, L.P., linked to Alphabet) has updated its passive stake in TScan Therapeutics. While this specific filing doesn't detail the change in share count, it signals ongoing institutional interest. Investors should monitor subsequent filings for specific changes in ownership percentages and consider this as part of their broader due diligence on TScan Therapeutics.

Key Numbers

Key Players & Entities

Forward-Looking Statements

FAQ

What is the purpose of an SC 13G/A filing?

An SC 13G/A is an amendment to a Schedule 13G, which is filed by passive investors who own more than 5% of a company's stock but do not intend to influence or control the company. The '/A' indicates it's an amendment to a previously filed statement, updating the information.

Who is the reporting person in this filing?

The reporting person is GV 2017, L.P., as stated on Page 2 of 17, under 'NAME OF REPORTING PERSONS'.

What is the subject company of this filing?

The subject company is TScan Therapeutics, Inc., as indicated in the 'Name of Issuer' section on the cover page and in the 'SUBJECT COMPANY' data block.

What is the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' is December 31, 2023, as specified on the cover page of the filing.

Under which rule was this Schedule 13G filed?

This Schedule 13G was filed under Rule 13d-1(d), as indicated by the checked box on the cover page.

From the Filing

0001104659-24-012937.txt : 20240209 0001104659-24-012937.hdr.sgml : 20240209 20240209160806 ACCESSION NUMBER: 0001104659-24-012937 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240209 GROUP MEMBERS: ALPHABET HOLDINGS LLC GROUP MEMBERS: ALPHABET INC. GROUP MEMBERS: GV 2017 GP, L.L.C. GROUP MEMBERS: GV 2017 GP, L.P. GROUP MEMBERS: GV 2019 GP, L.L.C. GROUP MEMBERS: GV 2019 GP, L.P. GROUP MEMBERS: GV 2019, L.P. GROUP MEMBERS: XXVI HOLDINGS INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92700 FILM NUMBER: 24614869 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GV 2017, L.P. CENTRAL INDEX KEY: 0001733340 ORGANIZATION NAME: IRS NUMBER: 352587854 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1600 AMPHITHEATRE PARKWAY CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-335-5278 MAIL ADDRESS: STREET 1: 1600 AMPHITHEATRE PARKWAY CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 SC 13G/A 1 tm244701d2_sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* TScan Therapeutics, Inc. (Name of Issuer) Voting Common Stock, par value $0.0001 per share (Title of Class of Securities) 89854M101 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 13d-1(b) ¨ Rule 13d-1(c) x Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 2 of 17 CUSIP No. 89854M101 1 NAME OF REPORTING PERSONS GV 2017, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 641,848 7 SOLE DISPOSITIVE POWER. 0 8 SHARED DISPOSITIVE POWER 641,848 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 641,848 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 1.5% 12 TYPE OF REPORTING PERSON PN Page 3 of 17 CUSIP No. 89854M101 1 NAME OF REPORTING PERSONS GV 2017 GP, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) ¨ 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH: 5 SOLE VOTING POWER 0 6 SHARED VOTING POWER 641,848 7 SOLE DISPOSITIVE POWER. 0 8 SHARED DISPOSITIVE POWER 641,848 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 641,848 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 1.5% 12 TYPE OF REPORTING PERSON PN Page 4 of

View on Read The Filing